ADC Therapeutics SA: shareholders and insiders

ADCTNYSEHealthcare · Pharmaceutical Preparations

Price

$1.37

November 18, 2026Market cap $174M

What Ploutos Investor adds for ADC Therapeutics SA

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 8 fiscal years, from 2018
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

Notes on these figures

  • The interest the company pays is far more than the debt we can read would cost, so part of its borrowing is missing from the figures. We leave out the debt, net cash, enterprise value and the multiples built on them.

Insiders and their shares

Purchases and sales by officers and directors from Nov 19, 2025 to Jul 2, 2026, from their own Form 4 filings.

11 Form 4s

Insider trades start on February 9, 2024

Until lately ADC Therapeutics SA was a foreign company listed in the US. Officers of foreign companies do not report their purchases and sales, so there are none before. They are not missing on our side: they were never filed.

  1. Until 2023Foreign company (annual report on 20-F)
  2. March 2024Becomes a US filer (annual report on 10-K)
  3. February 9, 2024The first insider trade report (Form 4)

Bought on the market

–

nobody

Sold on the market

$20M

1 person

From Nov 19, 2025 to Nov 19, 2026, the days the chart shows. Change its range and the figures follow.

How the sales were made, as a share of their value

  • Under a set plan0%
  • The rest100%
  • Jun 30, 2026Mohamed ZakiChief Medical Officer
    Kind
  • Jun 30, 2026Peter J GrahamChief Legal Officer
    Kind
  • Jun 30, 2026Jose CarmonaChief Financial Officer
    Kind
  • Jun 30, 2026Ameet MallikChief Executive Officer
    Kind
  • Jun 3, 2026Robert AzelbyDirector
    Kind
  • Jun 3, 2026Ron SquarerDirector
    Kind
  • Jun 3, 2026Victor SandorDirector
    Kind
  • Jun 3, 2026Viviane MongesDirector
    Kind
  • Jun 3, 2026Peter HugDirector
    Kind
  • Jun 3, 2026Jean-pierre BizzariDirector
    Kind
  • Jun 3, 2026Timothy CoughlinDirector
    Kind
  • Jun 1, 2026Robert AzelbyDirector
    Kind
  • Jun 1, 2026Ron SquarerDirector
    Kind
  • Jun 1, 2026Victor SandorDirector
    Kind
  • Jun 1, 2026Viviane MongesDirector
    Kind
  • Jun 1, 2026Peter HugDirector
    Kind
  • Jun 1, 2026Jean-pierre BizzariDirector
    Kind
  • Jun 1, 2026Timothy CoughlinDirector
    Kind
  • Apr 2, 2026RedCo II Master Fund, L.P.
    Kind
  • Apr 2, 2026RedCo II Master Fund, L.P.
    Kind
  • Apr 1, 2026RedCo II Master Fund, L.P.
    Kind
  • Apr 1, 2026RedCo II Master Fund, L.P.
    Kind
  • Mar 31, 2026RedCo II Master Fund, L.P.
    Kind
  • Mar 31, 2026RedCo II Master Fund, L.P.
    Kind

From the Form 4s insiders file with the SEC within two business days of each trade. Before Jun 3, 2026 the table lists open-market purchases and sales only (no grants, option exercises or tax withholding), from the SEC's quarterly data sets. The 10b5-1 mark comes from the form's own box (since April 2023) or from a footnote of the filing that names the plan, where there is one.

Insiders and their shares

Every buy and sale by ADCT's officers and directors from 2024 up to November 18, 2025, 2 more calendar years

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 3 years.

Major holders (over 5%)

Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.

7 Holders over 5%Oct 29, 2026 Latest filing
  • Bain Capital Life Sciences Opportunities IV, L.P.Common Shares, par value CHF 0.08 per share
    Share of class9.99%
  • Redmile Group, LLCwith 3 more personsCommon Shares, par value CHF 0.08 per share
    Share of class9.90%
  • Nantahala Capital Management, LLCwith 2 more personsCommon Shares, par value CHF 0.08 per share
    Share of class9.69%
  • Hpwh Thwith 2 more personsCommon Shares, par value CHF 0.08 per share
    Share of class9.61%
  • TCG Crossover GP II, LLCwith 2 more personsCommon Shares, par value CHF $0.08 per share
    Share of class9.20%
  • Prosight Management, LPwith 4 more personsCommon Shares
    Share of class6.80%
  • BlackRock, Inc.
    Share of class5.40%
Fell to 5% or less (3)

Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.

  • Orbimed Advisors2.60%Feb 17, 202613G/A
  • Point72 Asset Management, L.P.4.00%Feb 17, 202613G/A
  • Oaktree Fund Administration, LLC4.14%Nov 5, 202513G/A

From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.

Well-known managers

Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.

Sep 30, 2026 quarter end
  • Point72 (Cohen)
    In the quarter-88%
  • Citadel Advisors (Griffin)
    In the quarter+19%
  • Millennium Mgmt (Englander)
    In the quarter
  • D.E. Shaw
    In the quarter+111%
  • Renaissance Technologies
    In the quarter
  • AQR Capital
    In the quarter+242%

From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).

Short interest

How many of the company's shares have been sold borrowed and not yet bought back, twice a month.

On Oct 15, 2026, 4.99% of its shares outstanding were held short, -8.1% since the report before.

Shares held short
6.34M
4.99%
Since the report before6.90M on Sep 30, 2026
-8.1%
2.9
2.16M
More days to cover thanof 4,578 US-listed companies with enough volume
34%
Report date
Oct 15, 2026
  • Oct 31, 2023: Shares held short 3.97M
  • Nov 15, 2023: Shares held short 3.62M
  • Nov 30, 2023: Shares held short 4.09M
  • Dec 15, 2023: Shares held short 4.05M
  • Dec 29, 2023: Shares held short 3.72M
  • Jan 12, 2024: Shares held short 3.36M
  • Jan 31, 2024: Shares held short 2.93M
  • Feb 15, 2024: Shares held short 1.43M
  • Feb 29, 2024: Shares held short 868.8K
  • Mar 15, 2024: Shares held short 939.7K
  • Mar 28, 2024: Shares held short 993.1K
  • Apr 15, 2024: Shares held short 888.1K
  • Apr 30, 2024: Shares held short 857.6K
  • May 15, 2024: Shares held short 1.00M
  • May 31, 2024: Shares held short 982.5K
  • Jun 14, 2024: Shares held short 822.4K
  • Jun 28, 2024: Shares held short 819.5K
  • Jul 15, 2024: Shares held short 3.19M
  • Jul 31, 2024: Shares held short 3.00M
  • Aug 15, 2024: Shares held short 2.97M
  • Aug 30, 2024: Shares held short 2.71M
  • Sep 13, 2024: Shares held short 3.14M
  • Sep 30, 2024: Shares held short 3.56M
  • Oct 15, 2024: Shares held short 3.51M
  • Oct 31, 2024: Shares held short 3.17M
  • Nov 15, 2024: Shares held short 3.16M
  • Nov 29, 2024: Shares held short 3.01M
  • Dec 13, 2024: Shares held short 4.12M
  • Dec 31, 2024: Shares held short 4.86M
  • Jan 15, 2025: Shares held short 5.18M
  • Jan 31, 2025: Shares held short 4.86M
  • Feb 14, 2025: Shares held short 4.87M
  • Feb 28, 2025: Shares held short 5.30M
  • Mar 14, 2025: Shares held short 4.56M
  • Mar 31, 2025: Shares held short 4.29M
  • Apr 15, 2025: Shares held short 4.53M
  • Apr 30, 2025: Shares held short 4.47M
  • May 15, 2025: Shares held short 4.33M
  • May 30, 2025: Shares held short 4.27M
  • Jun 13, 2025: Shares held short 4.53M
  • Jun 30, 2025: Shares held short 4.91M
  • Jul 15, 2025: Shares held short 5.46M
  • Jul 31, 2025: Shares held short 5.68M
  • Aug 15, 2025: Shares held short 4.51M
  • Aug 29, 2025: Shares held short 4.14M
  • Sep 15, 2025: Shares held short 4.07M
  • Sep 30, 2025: Shares held short 5.30M
  • Oct 15, 2025: Shares held short 6.37M
  • Oct 31, 2025: Shares held short 6.48M
  • Nov 14, 2025: Shares held short 5.87M
  • Nov 28, 2025: Shares held short 6.03M
  • Dec 15, 2025: Shares held short 6.77M
  • Dec 31, 2025: Shares held short 3.57M
  • Jan 15, 2026: Shares held short 3.83M
  • Jan 30, 2026: Shares held short 4.42M
  • Feb 13, 2026: Shares held short 4.36M
  • Feb 27, 2026: Shares held short 4.11M
  • Mar 13, 2026: Shares held short 4.29M
  • Mar 31, 2026: Shares held short 4.90M
  • Apr 15, 2026: Shares held short 5.14M
  • Apr 30, 2026: Shares held short 5.47M
  • May 15, 2026: Shares held short 5.75M
  • May 29, 2026: Shares held short 6.07M
  • Jun 15, 2026: Shares held short 6.00M
  • Jun 30, 2026: Shares held short 5.99M
  • Jul 15, 2026: Shares held short 5.53M
  • Jul 31, 2026: Shares held short 5.09M
  • Aug 14, 2026: Shares held short 6.18M
  • Aug 31, 2026: Shares held short 6.29M
  • Sep 15, 2026: Shares held short 5.39M
  • Sep 30, 2026: Shares held short 6.90M
  • Oct 15, 2026: Shares held short 6.34M

As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.

Short sales in daily trading46.4% of the shares in the last 14 sessions' reported trades were short sales.

In the last 14 sessions, 46.4% of the shares in the reported trades were short sales, against 39.4% in the 14 before.

Last 14 sessionsOct 30, 2026 – Nov 18, 2026
46.4%
The 14 beforeOct 12, 2026 – Oct 29, 2026
39.4%
Change
+7.0 pts
Short sales a dayon average, of 592.5K shares
275.2K
More than atof 3,656 US-listed companies, same days
36%
Median of alleight in ten from 34.4% to 63.7%
50.3%
  • Oct 12, 2026: Short sales 26.9%
  • Oct 13, 2026: Short sales 25.6%
  • Oct 14, 2026: Short sales 46%
  • Oct 15, 2026: Short sales 41.2%
  • Oct 16, 2026: Short sales 58.8%
  • Oct 19, 2026: Short sales 41.7%
  • Oct 20, 2026: Short sales 55.9%
  • Oct 21, 2026: Short sales 44.5%
  • Oct 22, 2026: Short sales 45.5%
  • Oct 23, 2026: Short sales 49.7%
  • Oct 26, 2026: Short sales 55.1%
  • Oct 27, 2026: Short sales 56.6%
  • Oct 28, 2026: Short sales 35.5%
  • Oct 29, 2026: Short sales 17.8%
  • Oct 30, 2026: Short sales 30.1%
  • Nov 2, 2026: Short sales 34.5%
  • Nov 3, 2026: Short sales 40.6%
  • Nov 4, 2026: Short sales 31.4%
  • Nov 5, 2026: Short sales 70.5%
  • Nov 6, 2026: Short sales 42.2%
  • Nov 9, 2026: Short sales 63.9%
  • Nov 10, 2026: Short sales 18.1%
  • Nov 11, 2026: Short sales 52.9%
  • Nov 12, 2026: Short sales 70.1%
  • Nov 13, 2026: Short sales 44.9%
  • Nov 16, 2026: Short sales 50.1%
  • Nov 17, 2026: Short sales 43.6%
  • Nov 18, 2026: Short sales 43.1%

This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.

What the insiders hold

The shares each insider reports holding after their latest trade (Form 4), for those who traded on the market in the last three years.

57.79M Insiders' shares45.49% Of the company
  • Jeremy GreenTenPercentOwner
    Directly13.15M
  • RedCo II Master Fund, L.P.TenPercentOwner
    Directly10.27M
  • Ameet MallikChief Executive Officer
    Directly2.12M
  • Jose CarmonaChief Financial Officer
    Directly938.1K
  • Mohamed ZakiChief Medical Officer
    Directly896.3K
  • Peter J GrahamChief Legal Officer
    Directly841.6K
  • Peter HugDirector
    Directly263.3K
  • Thomas PfistererDirector
    Directly213.9K
  • Viviane MongesDirector
    Directly186.4K
  • Victor SandorDirector
    Directly140.7K
  • Jean-pierre BizzariDirector
    Directly139.3K
  • Ron SquarerDirector
    Directly123.4K
  • Robert AzelbyDirector
    Directly112.8K
  • Timothy CoughlinDirector
    Directly72.4K

A lower bound: it counts only the 14 officers and directors with a market trade since Nov 20, 2023. Anyone who neither bought nor sold since is not here, whatever they hold. The share is against the share count on the latest 10-K's cover.

The ETFs that hold it

Which of the 345 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.

7 ETFs holding it0.03% The largest weight (IWC)
  • IWCiShares Micro-Cap ETF
    Weight in the fund0.03%
  • IBBiShares Biotechnology ETF
    Weight in the fund0.01%
  • IWNiShares Russell 2000 Value ETF
    Weight in the fund0.01%
  • VTWOVanguard Russell 2000 Index Fund
    Weight in the fund0.00%
  • IWMiShares Russell 2000 ETF
    Weight in the fund0.00%
  • IWOiShares Russell 2000 Growth ETF
    Weight in the fund0.00%
  • IWViShares Russell 3000 ETF
    Weight in the fund0.00%

7 of the 345 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.

Institutional investors by quarter

Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.

114 Managers, Q2 2026$100M Value of their positions
  • Q3 2025: Managers 106
  • Q4 2025: Managers 115
  • Q1 2026: Managers 119
  • Q2 2026: Managers 114

Institutional investors by quarter

The fund managers holding ADCT, quarter by quarter, from Q2 2020 to Q2 2025, 21 more quarters

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 12 quarters.

Q2 2026: 114 managers held 93.07M shares, worth $100M. During the quarter 27 opened a position, 31 closed one, 42 added and 29 trimmed.

The largest holders, Q2 2026

  • Nantahala Capital Management
    In the quarter+340%
  • Redmile Group
    In the quarter-25%
  • TCG Crossover Management
    In the quarter
  • Prosight Management
    In the quarter-5.7%
  • BlackRock
    In the quarter+12%
  • Point72 (Cohen)
    In the quarter+7.9%
  • Morgan Stanley
    In the quarter-20%
  • Millennium Mgmt (Englander)
    In the quarter-7.0%
  • Citadel Advisors (Griffin)
    In the quarter+414%
  • Goldman Sachs Group
    In the quarter+16%

From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.

Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.

The full analysis

What do ADC Therapeutics SA's filings show?

Who buys and sells is one part of ADC Therapeutics SA's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

Questions about ADCT's shareholders

Didn't find what you were looking for?

Ask us
Have ADCT's insiders bought or sold?

From Jun 3, 2026 to Jul 2, 2026 ADC Therapeutics SA's insiders reported no purchase or sale of shares on the market.

Which well-known managers hold ADCT?

6 of the managers we track held the shares on Sep 30, 2026. The largest position was Citadel Advisors (Griffin)'s, worth $3.0M.

Is every insider transaction a purchase or a sale?

No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.